Next Article in Journal
Synthetic Medicinal Chemistry in Chagas’ Disease: Compounds at The Final Stage of “Hit-To-Lead” Phase
Next Article in Special Issue
Antiproliferative Properties of Type I and Type II Interferon
Previous Article in Journal
Implications of Inter-Individual Differences in Clopidogrel Metabolism, with Focus on Pharmacogenetics
Previous Article in Special Issue
Deregulation of Interferon Signaling in Malignant Cells
Pharmaceuticals 2010, 3(4), 795-809; doi:10.3390/ph3040795

Notes on Article Versions

article html file updated18 January 2013 03:44 CET
article html file updated21 January 2013 21:51 CET
article html file updated25 January 2013 21:30 CET
article html file updated28 January 2013 18:39 CET
article html file updated5 February 2013 21:06 CET
article html file updated6 February 2013 16:56 CET
article xml file uploaded5 June 2014 08:48 CEST
article html file updated5 June 2014 08:48 CEST
article xml file uploaded14 August 2014 12:04 CEST
article html file updated14 August 2014 12:04 CEST
article html file updated16 June 2015 08:49 CEST
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert